Inventor

BRETON LIONEL

FR108 patents

⚠️ This page may combine multiple inventors who share the name “BRETON LIONEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRETON LIONEL

OREAL

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin

Topical composition containing a substance P antagoinst

Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same

Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition

Hydroxystilbene/ascorbic acid compositions for treating skin afflictions

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discreet erythema

Cosmetic/pharmaceutical compositions comprising microorganism culture media

Topical composition containing capsazepine

Cosmetic/dermatological skin care compositions comprising S-DHEA

Topical composition containing a substance P antagonist

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating skin redness/rosacea/discrete erythema

Compositions and methods for treating wrinkles and/or fine lines of the skin

Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it

Hydroxystilbene/ascorbic acid compositions for treating skin afflictions

Promoting epidermal renewal with phloroglucinol

Skin toning by stimulating collagen synthesis/proliferation of dermal fibroblasts

C-glycoside compounds for stimulating the synthesis of glycosaminoglycans

Composition, in particular cosmetic, containing 7-hydroxy DHEA and/or 7-keto DHEA and at least an isoflavonoid

Iridaceae extract and compositions containing it

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids

Lip care composition containing acexamic acid, and uses thereof

Alkaline-earth metal salt for the treatment of ocular or palpebral pruritus and dysesthesia

Compositions and methods for treating wrinkles and/or fine lines of the skin

Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin

Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same

Method for treating neurogenic red skin blotches with compositions containing TNF-alpha antagonists

Antiperspirant compositions comprising substance P antagonists

Substance P antagonist for the treatment of lichens, prurigo, pruritus

Compounds of the N-acylamino amide family, compositions comprising same, and uses

Compounds derived from benzoic acid esters, composition containing said compounds and use thereof

Administration of lycopene for combating skin/mucous membrane damage

Compounds derived from benzoic acid esters, composition containing said compounds and use thereof

Polyholoside compositions for beneficially treating the skin

Cosmetic/pharmaceutical compositions comprising β-adrenergic agonists/substance P antagonists

Substance P antagonists comprising rosaceae plant extracts

Desquamation/epidermal renewal of the skin and/or combating skin aging

Method for preventing or treating disorders involving an inflammatory process

Histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained

Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition

Excitatory amino acid inhibitors for treating sensitive skins

Cosmetic composition containing at least one auxin and its use

Treating skin wrinkles/fine lines with calcium channel inhibitors

Anti-inflammatory compositions comprising peptide derivatives of α-MSH/algal extracts

Use of cinnamic acid or of its derivatives in a cosmetic firming composition

Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists

Methods and compositions for preventing and treating sensitive and dry skin

SOCIETEL OREAL S A

Use of a salt of an alkaline-earth metal as TNF-A or substance P inhibitor in a topical composition and composition obtained

Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists

Cosmetic/dermatological skin care compositions comprising S-DHEA

Composition for dyeing keratin fibres containing a substance P antagonist